Video Experimental Relacionado
Updated: May 5, 2026
07:26
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.9K
El nuevo alelo HLA-DPB1*1650:01 N fue identificado por secuenciación de próxima generación
Min-Kyung So1, Seunghwan Kim1, Sori Lim2
1Department of Laboratory Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
HLA
|August 27, 2025
Resumen
Un nuevo alelo HLA-DPB1*1650:01:01:01 difiere de HLA-DPB1*135:01:01 debido a un cambio de un solo nucleótido, lo que resulta en un codón de parada prematuro en el exón 2.
Área de la Ciencia:
- La inmunogenética
- Biología molecular
Sus antecedentes:
- El antígeno leucocitario humano (HLA) juega un papel crítico en las respuestas inmunes.
- Los polimorfismos en los genes HLA, particularmente HLA-DPB1, influyen en la función del sistema inmunológico y la susceptibilidad a las enfermedades.
Objetivo del estudio:
- Para caracterizar un alelo HLA-DPB1 recién identificado, designado HLA-DPB1*1650:01:01.
- Identificar las variaciones genéticas específicas que distinguen este nuevo alelo de los alelos conocidos.
Principales métodos:
- Análisis de la secuencia del gen HLA-DPB1.
- Comparación de la nueva secuencia alélica con las secuencias de referencia HLA-DPB1 existentes.
Principales resultados:
- Se identificó el nuevo alelo HLA-DPB1*1650:01:01.
- Este alelo difiere de HLA-DPB1*135:01:01 en el exón 2, codón 62, con una sustitución de nucleótidos de CAG a TAG.
- Esta sustitución da lugar a una parada prematura del codón.
Conclusiones:
- El descubrimiento de HLA-DPB1*1650:01:01:01 amplía el conocido repertorio de alelos HLA-DPB1.
- El codón de parada prematura puede afectar la función y la expresión de la proteína HLA-DPB1.
Videos de Conceptos Relacionados
03:00Next-generation Sequencing
87.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.9K
01:05Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
01:11Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K